

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.27962163 |
| 2 | cellular response to exogenous dsRNA (GO:0071360) | 4.67211048 |
| 3 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.60982463 |
| 4 | positive thymic T cell selection (GO:0045059) | 4.56867457 |
| 5 | negative regulation of B cell apoptotic process (GO:0002903) | 4.46248796 |
| 6 | positive regulation of granulocyte differentiation (GO:0030854) | 4.45220979 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 4.36890334 |
| 8 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 4.20429008 |
| 9 | cellular response to interferon-beta (GO:0035458) | 4.12653461 |
| 10 | response to muramyl dipeptide (GO:0032495) | 4.03179771 |
| 11 | definitive hemopoiesis (GO:0060216) | 3.89379743 |
| 12 | mannose metabolic process (GO:0006013) | 3.88784246 |
| 13 | response to peptidoglycan (GO:0032494) | 3.86738567 |
| 14 | response to protozoan (GO:0001562) | 3.83714342 |
| 15 | defense response to protozoan (GO:0042832) | 3.83516257 |
| 16 | UV protection (GO:0009650) | 3.75967170 |
| 17 | dosage compensation (GO:0007549) | 3.71646379 |
| 18 | response to interferon-beta (GO:0035456) | 3.71274845 |
| 19 | thrombin receptor signaling pathway (GO:0070493) | 3.66910897 |
| 20 | purine nucleotide salvage (GO:0032261) | 3.63917300 |
| 21 | autophagic vacuole fusion (GO:0000046) | 3.60663852 |
| 22 | negative thymic T cell selection (GO:0045060) | 3.58480775 |
| 23 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.52645470 |
| 24 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.51098352 |
| 25 | protein polyglutamylation (GO:0018095) | 3.46577572 |
| 26 | regulation of erythrocyte differentiation (GO:0045646) | 3.46286380 |
| 27 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.44191562 |
| 28 | pentose metabolic process (GO:0019321) | 3.38770832 |
| 29 | regulation of B cell apoptotic process (GO:0002902) | 3.37192821 |
| 30 | regulation of respiratory burst (GO:0060263) | 3.27908076 |
| 31 | oligosaccharide catabolic process (GO:0009313) | 3.26438384 |
| 32 | sleep (GO:0030431) | 3.25325854 |
| 33 | thymic T cell selection (GO:0045061) | 3.24410930 |
| 34 | regulation of B cell differentiation (GO:0045577) | 3.23095225 |
| 35 | negative T cell selection (GO:0043383) | 3.23038584 |
| 36 | regulation of granulocyte differentiation (GO:0030852) | 3.23035994 |
| 37 | mast cell degranulation (GO:0043303) | 3.23026097 |
| 38 | mast cell activation involved in immune response (GO:0002279) | 3.23026097 |
| 39 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.22632038 |
| 40 | leukocyte aggregation (GO:0070486) | 3.17581035 |
| 41 | imidazole-containing compound metabolic process (GO:0052803) | 3.15331391 |
| 42 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.14225343 |
| 43 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.10222723 |
| 44 | pinocytosis (GO:0006907) | 3.10151772 |
| 45 | positive T cell selection (GO:0043368) | 3.09806774 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 3.09217546 |
| 47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.05425990 |
| 48 | regulation of antigen processing and presentation (GO:0002577) | 3.03146378 |
| 49 | DNA deamination (GO:0045006) | 2.97783518 |
| 50 | histone H2A acetylation (GO:0043968) | 2.97464610 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92530324 |
| 52 | response to gravity (GO:0009629) | 2.90940573 |
| 53 | organelle membrane fusion (GO:0090174) | 2.89212943 |
| 54 | nucleotide salvage (GO:0043173) | 2.89007607 |
| 55 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.84997445 |
| 56 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.84997445 |
| 57 | peptidyl-lysine trimethylation (GO:0018023) | 2.84429182 |
| 58 | endothelium development (GO:0003158) | 2.82534230 |
| 59 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.81605503 |
| 60 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.81371941 |
| 61 | grooming behavior (GO:0007625) | 2.78249201 |
| 62 | Peyers patch development (GO:0048541) | 2.75063614 |
| 63 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.75063614 |
| 64 | estrogen biosynthetic process (GO:0006703) | 2.74094470 |
| 65 | cellular hyperosmotic response (GO:0071474) | 2.74046258 |
| 66 | glycosphingolipid catabolic process (GO:0046479) | 2.73500338 |
| 67 | seminiferous tubule development (GO:0072520) | 2.73085374 |
| 68 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.71838231 |
| 69 | T cell migration (GO:0072678) | 2.66137468 |
| 70 | regulation of penile erection (GO:0060405) | 2.65185518 |
| 71 | mast cell activation (GO:0045576) | 2.65024831 |
| 72 | peptidyl-arginine methylation (GO:0018216) | 2.64570398 |
| 73 | peptidyl-arginine N-methylation (GO:0035246) | 2.64570398 |
| 74 | response to exogenous dsRNA (GO:0043330) | 2.59940466 |
| 75 | GDP-mannose metabolic process (GO:0019673) | 2.58657465 |
| 76 | DNA strand renaturation (GO:0000733) | 2.58548014 |
| 77 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.58017452 |
| 78 | valine metabolic process (GO:0006573) | 2.57622795 |
| 79 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.56892186 |
| 80 | B cell receptor signaling pathway (GO:0050853) | 2.56417416 |
| 81 | positive regulation of antigen processing and presentation (GO:0002579) | 2.55113720 |
| 82 | branched-chain amino acid catabolic process (GO:0009083) | 2.54655775 |
| 83 | positive regulation of protein kinase C signaling (GO:0090037) | 2.54542188 |
| 84 | cellular response to dsRNA (GO:0071359) | 2.50560551 |
| 85 | actin nucleation (GO:0045010) | 2.50432410 |
| 86 | histone H3-K9 methylation (GO:0051567) | 2.50223421 |
| 87 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.49450408 |
| 88 | purine-containing compound salvage (GO:0043101) | 2.49435807 |
| 89 | T cell selection (GO:0045058) | 2.49044296 |
| 90 | axoneme assembly (GO:0035082) | 2.44594655 |
| 91 | histone H3-K36 demethylation (GO:0070544) | 2.44188093 |
| 92 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.43802767 |
| 93 | glycolipid catabolic process (GO:0019377) | 2.41466550 |
| 94 | branched-chain amino acid metabolic process (GO:0009081) | 2.40153491 |
| 95 | B cell mediated immunity (GO:0019724) | 2.39105410 |
| 96 | hyaluronan catabolic process (GO:0030214) | 2.38354974 |
| 97 | aggressive behavior (GO:0002118) | 2.37440292 |
| 98 | glutathione biosynthetic process (GO:0006750) | 2.36731253 |
| 99 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.36421431 |
| 100 | viral mRNA export from host cell nucleus (GO:0046784) | 2.33181485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.16236960 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.38692618 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.02394686 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.96065811 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.84734521 |
| 6 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.51512469 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.49155653 |
| 8 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.29790674 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.27976285 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23573577 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16042157 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.15521118 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13978335 |
| 14 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.99857652 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.92821885 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 1.91084598 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89801264 |
| 18 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.88092385 |
| 19 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.86034124 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 1.85266435 |
| 21 | P68_20966046_ChIP-Seq_HELA_Human | 1.83363381 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81670964 |
| 23 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76587029 |
| 24 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76048703 |
| 25 | MAF_26560356_Chip-Seq_TH2_Human | 1.75802346 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.74693147 |
| 27 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.74678010 |
| 28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.74200501 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74075743 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72528386 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70866477 |
| 32 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.70311416 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69928612 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63805831 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.60289775 |
| 36 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.56951673 |
| 37 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.55289675 |
| 38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.53935651 |
| 39 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.50814375 |
| 40 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47406889 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46929461 |
| 42 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.45772692 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44646247 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.44376217 |
| 45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.44201788 |
| 46 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.42569641 |
| 47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.41842737 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.41774181 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.41339153 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38559309 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38323869 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.36993708 |
| 53 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.36817620 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34152069 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34069147 |
| 56 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.33812929 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33646295 |
| 58 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.33392287 |
| 59 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33273474 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32420528 |
| 61 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.31557101 |
| 62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31483609 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30714037 |
| 64 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30638421 |
| 65 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.30445980 |
| 66 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.29546510 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29508312 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28268488 |
| 69 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.27543078 |
| 70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27247192 |
| 71 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.26955011 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25487351 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24167301 |
| 74 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.23346662 |
| 75 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23208233 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22660313 |
| 77 | P300_27268052_Chip-Seq_Bcells_Human | 1.21888606 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21380742 |
| 79 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.21314590 |
| 80 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.21287816 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20492725 |
| 82 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19746456 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18992802 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18981547 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17096972 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16931723 |
| 87 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.15836060 |
| 88 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.15737582 |
| 89 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.12512092 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12136277 |
| 91 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11927860 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11330496 |
| 93 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10284408 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09613061 |
| 95 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.09255906 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08814019 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08197307 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07921564 |
| 99 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07235599 |
| 100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06542123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008875_abnormal_xenobiotic_pharmacok | 4.00098216 |
| 2 | MP0003436_decreased_susceptibility_to | 3.49801719 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.88969311 |
| 4 | MP0005464_abnormal_platelet_physiology | 2.87611987 |
| 5 | MP0000372_irregular_coat_pigmentation | 2.87396426 |
| 6 | MP0003172_abnormal_lysosome_physiology | 2.65295374 |
| 7 | MP0009278_abnormal_bone_marrow | 2.60613170 |
| 8 | MP0002132_abnormal_respiratory_system | 2.58578713 |
| 9 | MP0001545_abnormal_hematopoietic_system | 2.55083215 |
| 10 | MP0005397_hematopoietic_system_phenotyp | 2.55083215 |
| 11 | MP0001986_abnormal_taste_sensitivity | 2.47897783 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.38863553 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.33178304 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.10392835 |
| 15 | MP0008260_abnormal_autophagy | 2.06218640 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.04682293 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.03634277 |
| 18 | MP0002398_abnormal_bone_marrow | 1.91625874 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.88793053 |
| 20 | MP0002419_abnormal_innate_immunity | 1.87913702 |
| 21 | MP0005025_abnormal_response_to | 1.86069631 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.77771933 |
| 23 | MP0004782_abnormal_surfactant_physiolog | 1.75478450 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.74206198 |
| 25 | MP0002723_abnormal_immune_serum | 1.73131381 |
| 26 | MP0001819_abnormal_immune_cell | 1.73012400 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.72020839 |
| 28 | MP0009697_abnormal_copulation | 1.70000458 |
| 29 | MP0000689_abnormal_spleen_morphology | 1.64110594 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.61947820 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.61499966 |
| 32 | MP0002722_abnormal_immune_system | 1.59156552 |
| 33 | MP0001800_abnormal_humoral_immune | 1.57431465 |
| 34 | MP0000716_abnormal_immune_system | 1.53987579 |
| 35 | MP0002405_respiratory_system_inflammati | 1.47299275 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.46033301 |
| 37 | MP0002429_abnormal_blood_cell | 1.44592286 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.42989842 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.40253467 |
| 40 | MP0001790_abnormal_immune_system | 1.38462565 |
| 41 | MP0005387_immune_system_phenotype | 1.38462565 |
| 42 | MP0005409_darkened_coat_color | 1.37352024 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.36426761 |
| 44 | MP0005220_abnormal_exocrine_pancreas | 1.35946243 |
| 45 | MP0003303_peritoneal_inflammation | 1.34191366 |
| 46 | MP0002019_abnormal_tumor_incidence | 1.33690103 |
| 47 | MP0005360_urolithiasis | 1.30280693 |
| 48 | MP0001853_heart_inflammation | 1.23144090 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.20824554 |
| 50 | MP0008007_abnormal_cellular_replicative | 1.19519981 |
| 51 | MP0005410_abnormal_fertilization | 1.18587381 |
| 52 | MP0009765_abnormal_xenobiotic_induced | 1.16651848 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.15797610 |
| 54 | MP0003866_abnormal_defecation | 1.15205709 |
| 55 | MP0008469_abnormal_protein_level | 1.14947144 |
| 56 | MP0009764_decreased_sensitivity_to | 1.12384256 |
| 57 | MP0000685_abnormal_immune_system | 1.09459117 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.07278169 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.05955501 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.02668386 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.01164033 |
| 62 | MP0008058_abnormal_DNA_repair | 1.00796980 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.00392302 |
| 64 | MP0005365_abnormal_bile_salt | 0.96208264 |
| 65 | MP0000681_abnormal_thyroid_gland | 0.95915946 |
| 66 | MP0005174_abnormal_tail_pigmentation | 0.95852959 |
| 67 | MP0009785_altered_susceptibility_to | 0.95498604 |
| 68 | MP0009763_increased_sensitivity_to | 0.94583846 |
| 69 | MP0001873_stomach_inflammation | 0.92672626 |
| 70 | MP0006054_spinal_hemorrhage | 0.91321167 |
| 71 | MP0004947_skin_inflammation | 0.91116278 |
| 72 | MP0000358_abnormal_cell_content/ | 0.88382071 |
| 73 | MP0001845_abnormal_inflammatory_respons | 0.88310806 |
| 74 | MP0008995_early_reproductive_senescence | 0.86643795 |
| 75 | MP0005330_cardiomyopathy | 0.84126714 |
| 76 | MP0005377_hearing/vestibular/ear_phenot | 0.83154429 |
| 77 | MP0003878_abnormal_ear_physiology | 0.83154429 |
| 78 | MP0004147_increased_porphyrin_level | 0.82464401 |
| 79 | MP0000383_abnormal_hair_follicle | 0.81318936 |
| 80 | MP0003718_maternal_effect | 0.80906255 |
| 81 | MP0009384_cardiac_valve_regurgitation | 0.80251789 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.79436059 |
| 83 | MP0002160_abnormal_reproductive_system | 0.79193304 |
| 84 | MP0002249_abnormal_larynx_morphology | 0.79097545 |
| 85 | MP0009379_abnormal_foot_pigmentation | 0.79018885 |
| 86 | MP0000598_abnormal_liver_morphology | 0.77289529 |
| 87 | MP0008873_increased_physiological_sensi | 0.76578686 |
| 88 | MP0001764_abnormal_homeostasis | 0.75687502 |
| 89 | MP0003300_gastrointestinal_ulcer | 0.75270993 |
| 90 | MP0006292_abnormal_olfactory_placode | 0.75229124 |
| 91 | MP0005171_absent_coat_pigmentation | 0.72180588 |
| 92 | MP0002282_abnormal_trachea_morphology | 0.71080152 |
| 93 | MP0000490_abnormal_crypts_of | 0.70360053 |
| 94 | MP0000858_altered_metastatic_potential | 0.70240636 |
| 95 | MP0005671_abnormal_response_to | 0.69611710 |
| 96 | MP0002933_joint_inflammation | 0.68760194 |
| 97 | MP0003724_increased_susceptibility_to | 0.65691622 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.64714358 |
| 99 | MP0008961_abnormal_basal_metabolism | 0.64360835 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.62539269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dyschromatopsia (HP:0007641) | 5.07889259 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.83902157 |
| 3 | Prolonged bleeding time (HP:0003010) | 4.59375386 |
| 4 | Attenuation of retinal blood vessels (HP:0007843) | 4.04943229 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 3.96398704 |
| 6 | Decreased central vision (HP:0007663) | 3.25613236 |
| 7 | Epistaxis (HP:0000421) | 3.09705871 |
| 8 | Seborrheic dermatitis (HP:0001051) | 3.04813942 |
| 9 | Myositis (HP:0100614) | 2.98848586 |
| 10 | Recurrent fungal infections (HP:0002841) | 2.95637821 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 2.84853278 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.84853278 |
| 13 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.83660589 |
| 14 | Microvesicular hepatic steatosis (HP:0001414) | 2.82746727 |
| 15 | Muscle stiffness (HP:0003552) | 2.80846039 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 2.71339548 |
| 17 | Obstructive lung disease (HP:0006536) | 2.71339548 |
| 18 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.70727897 |
| 19 | Abnormal protein glycosylation (HP:0012346) | 2.70727897 |
| 20 | Abnormal glycosylation (HP:0012345) | 2.70727897 |
| 21 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.70727897 |
| 22 | Petechiae (HP:0000967) | 2.67330334 |
| 23 | Hypertensive crisis (HP:0100735) | 2.59537077 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.59081171 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.59081171 |
| 26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.59081171 |
| 27 | Brushfield spots (HP:0001088) | 2.58929373 |
| 28 | Abnormality of the prostate (HP:0008775) | 2.55293792 |
| 29 | Hemorrhage of the eye (HP:0011885) | 2.54637150 |
| 30 | Aplastic anemia (HP:0001915) | 2.49730925 |
| 31 | Acute lymphatic leukemia (HP:0006721) | 2.48901650 |
| 32 | Basal cell carcinoma (HP:0002671) | 2.48837428 |
| 33 | Thrombocytosis (HP:0001894) | 2.46472730 |
| 34 | Agammaglobulinemia (HP:0004432) | 2.44769054 |
| 35 | Testicular atrophy (HP:0000029) | 2.42474138 |
| 36 | Dysautonomia (HP:0002459) | 2.42005190 |
| 37 | Dicarboxylic aciduria (HP:0003215) | 2.41252204 |
| 38 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.41252204 |
| 39 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.40628522 |
| 40 | Granulocytopenia (HP:0001913) | 2.39133723 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.37399751 |
| 42 | Progressive microcephaly (HP:0000253) | 2.34415215 |
| 43 | Spastic paraparesis (HP:0002313) | 2.32660500 |
| 44 | Increased IgE level (HP:0003212) | 2.31610573 |
| 45 | 3-Methylglutaconic aciduria (HP:0003535) | 2.31118623 |
| 46 | Abnormality of B cell number (HP:0010975) | 2.30998934 |
| 47 | Joint stiffness (HP:0001387) | 2.30928168 |
| 48 | Joint hemorrhage (HP:0005261) | 2.30399016 |
| 49 | Mucopolysacchariduria (HP:0008155) | 2.30177046 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.30177046 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.28177732 |
| 52 | Type I transferrin isoform profile (HP:0003642) | 2.27544990 |
| 53 | Pustule (HP:0200039) | 2.21459970 |
| 54 | Chest pain (HP:0100749) | 2.20471631 |
| 55 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19065667 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19065667 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19065667 |
| 58 | Increased serum ferritin (HP:0003281) | 2.19036293 |
| 59 | Bile duct proliferation (HP:0001408) | 2.18361381 |
| 60 | Abnormal biliary tract physiology (HP:0012439) | 2.18361381 |
| 61 | Chronic otitis media (HP:0000389) | 2.17245702 |
| 62 | Mesangial abnormality (HP:0001966) | 2.15753319 |
| 63 | Abnormality of macular pigmentation (HP:0008002) | 2.15321320 |
| 64 | Recurrent viral infections (HP:0004429) | 2.14931529 |
| 65 | Prostate neoplasm (HP:0100787) | 2.14887547 |
| 66 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.13443242 |
| 67 | Increased muscle lipid content (HP:0009058) | 2.11415178 |
| 68 | Thin bony cortex (HP:0002753) | 2.10140005 |
| 69 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.09526045 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.08016829 |
| 71 | Prolonged partial thromboplastin time (HP:0003645) | 2.06205862 |
| 72 | Failure to thrive in infancy (HP:0001531) | 2.05236059 |
| 73 | Hepatosplenomegaly (HP:0001433) | 2.04451267 |
| 74 | Cellulitis (HP:0100658) | 2.02053703 |
| 75 | B lymphocytopenia (HP:0010976) | 2.01641162 |
| 76 | Truncus arteriosus (HP:0001660) | 2.00747982 |
| 77 | Progressive muscle weakness (HP:0003323) | 2.00713351 |
| 78 | Abnormality of male internal genitalia (HP:0000022) | 1.97705706 |
| 79 | Thoracic kyphosis (HP:0002942) | 1.91820006 |
| 80 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.91630505 |
| 81 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91422355 |
| 82 | Abnormality of the peritoneum (HP:0002585) | 1.89468776 |
| 83 | Vacuolated lymphocytes (HP:0001922) | 1.88312048 |
| 84 | Meningitis (HP:0001287) | 1.88142842 |
| 85 | Annular pancreas (HP:0001734) | 1.88092786 |
| 86 | Encephalitis (HP:0002383) | 1.87970416 |
| 87 | Autoimmune hemolytic anemia (HP:0001890) | 1.87022298 |
| 88 | Abnormality of the costochondral junction (HP:0000919) | 1.86806559 |
| 89 | Hepatocellular necrosis (HP:0001404) | 1.85283298 |
| 90 | Cheilitis (HP:0100825) | 1.85217978 |
| 91 | Episodic fever (HP:0001954) | 1.84953637 |
| 92 | Epiphyseal stippling (HP:0010655) | 1.84558118 |
| 93 | Recurrent skin infections (HP:0001581) | 1.83933878 |
| 94 | Progressive external ophthalmoplegia (HP:0000590) | 1.83613673 |
| 95 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83202567 |
| 96 | Delayed epiphyseal ossification (HP:0002663) | 1.82883964 |
| 97 | Fatigue (HP:0012378) | 1.82748544 |
| 98 | J-shaped sella turcica (HP:0002680) | 1.82512651 |
| 99 | Abnormal epiphyseal ossification (HP:0010656) | 1.82156531 |
| 100 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79162593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.30742001 |
| 2 | VRK2 | 3.27528347 |
| 3 | MAP2K3 | 3.19213413 |
| 4 | MAP4K1 | 3.15441184 |
| 5 | SRPK1 | 3.01306503 |
| 6 | BCKDK | 2.97037581 |
| 7 | KIT | 2.45067172 |
| 8 | MAPK15 | 2.43427427 |
| 9 | TBK1 | 2.39910691 |
| 10 | TAOK3 | 2.25762668 |
| 11 | FLT3 | 2.18694773 |
| 12 | TESK2 | 2.15776360 |
| 13 | TNK2 | 2.06795048 |
| 14 | SMG1 | 1.95575997 |
| 15 | PRPF4B | 1.93970082 |
| 16 | FES | 1.88726292 |
| 17 | GRK6 | 1.84293759 |
| 18 | SCYL2 | 1.76349221 |
| 19 | NUAK1 | 1.66660372 |
| 20 | CSF1R | 1.58148175 |
| 21 | IRAK2 | 1.57434778 |
| 22 | PIM2 | 1.56929674 |
| 23 | ZAP70 | 1.54006994 |
| 24 | MAP3K14 | 1.52781130 |
| 25 | MAP3K11 | 1.52526459 |
| 26 | IKBKB | 1.51810233 |
| 27 | STK16 | 1.48296593 |
| 28 | BTK | 1.47078739 |
| 29 | MAP2K2 | 1.39848951 |
| 30 | TRIB3 | 1.35509245 |
| 31 | SYK | 1.33709375 |
| 32 | MAP2K6 | 1.31936993 |
| 33 | TEC | 1.21488655 |
| 34 | IRAK1 | 1.14521849 |
| 35 | JAK3 | 1.12578977 |
| 36 | TAOK2 | 1.10255343 |
| 37 | LRRK2 | 1.08487571 |
| 38 | ITK | 1.03105938 |
| 39 | PRKD2 | 1.00816327 |
| 40 | IKBKE | 0.99920194 |
| 41 | TXK | 0.97515544 |
| 42 | HCK | 0.97306989 |
| 43 | BLK | 0.88742847 |
| 44 | CCNB1 | 0.86840913 |
| 45 | VRK1 | 0.83597291 |
| 46 | CDK9 | 0.81580463 |
| 47 | EIF2AK2 | 0.81172950 |
| 48 | LCK | 0.79346124 |
| 49 | MAP3K6 | 0.78266572 |
| 50 | RPS6KC1 | 0.78157946 |
| 51 | RPS6KL1 | 0.78157946 |
| 52 | BMX | 0.77239959 |
| 53 | WNK4 | 0.76746461 |
| 54 | PRKCQ | 0.74176169 |
| 55 | PKN2 | 0.73593460 |
| 56 | EPHB1 | 0.73347745 |
| 57 | ATR | 0.72903258 |
| 58 | RPS6KA6 | 0.72864639 |
| 59 | MAP3K13 | 0.72460384 |
| 60 | RPS6KA2 | 0.67290307 |
| 61 | NME2 | 0.67280294 |
| 62 | SIK3 | 0.66556038 |
| 63 | KDR | 0.66536089 |
| 64 | RPS6KA5 | 0.65659879 |
| 65 | SIK1 | 0.63747478 |
| 66 | MAPK11 | 0.62913327 |
| 67 | MATK | 0.59346746 |
| 68 | RIPK4 | 0.58963457 |
| 69 | MAPK7 | 0.58732837 |
| 70 | MAP2K4 | 0.58047956 |
| 71 | LYN | 0.56869122 |
| 72 | CDK7 | 0.56005204 |
| 73 | MAPK3 | 0.55841726 |
| 74 | CDK12 | 0.54497696 |
| 75 | TYK2 | 0.48639439 |
| 76 | ADRBK1 | 0.48399687 |
| 77 | SIK2 | 0.47860928 |
| 78 | RPS6KA1 | 0.47739423 |
| 79 | MARK2 | 0.47613819 |
| 80 | CHUK | 0.46740432 |
| 81 | DYRK1B | 0.46658106 |
| 82 | PRKCI | 0.46597201 |
| 83 | MAP3K1 | 0.46530742 |
| 84 | PDPK1 | 0.44604654 |
| 85 | RAF1 | 0.44345900 |
| 86 | IRAK4 | 0.44196308 |
| 87 | CLK1 | 0.43719186 |
| 88 | CDK4 | 0.41497903 |
| 89 | CAMKK1 | 0.38831679 |
| 90 | MTOR | 0.38265979 |
| 91 | PKN1 | 0.37522759 |
| 92 | CSNK1G3 | 0.35636080 |
| 93 | PDK1 | 0.34154862 |
| 94 | MAPK4 | 0.34058460 |
| 95 | ARAF | 0.33855956 |
| 96 | BMPR1B | 0.33657702 |
| 97 | PASK | 0.32553847 |
| 98 | MAP3K7 | 0.31863062 |
| 99 | MARK3 | 0.31060248 |
| 100 | HIPK2 | 0.30331694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 5.62916193 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.04886797 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.91477038 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.85752098 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.65876425 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.32434205 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.32383416 |
| 8 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.31191488 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.27595927 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.09578874 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.97411962 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.93307723 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 1.89125642 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.87482770 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.76552992 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75204421 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74597391 |
| 18 | Sulfur relay system_Homo sapiens_hsa04122 | 1.60623449 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.56656091 |
| 20 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.56631253 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47591203 |
| 22 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.44004310 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41880759 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.40073345 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37994337 |
| 26 | RNA polymerase_Homo sapiens_hsa03020 | 1.34486622 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32295378 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22352041 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21469552 |
| 30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.21222088 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.16082132 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.13020692 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.09889001 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.06495146 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.06355137 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06061350 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.04482613 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04088457 |
| 39 | Spliceosome_Homo sapiens_hsa03040 | 0.98437000 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94553338 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 0.91972405 |
| 42 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91440579 |
| 43 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.89877501 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88368078 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87845798 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.87435812 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.86623391 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 0.86027926 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85603759 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.84769638 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84543296 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82626486 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.82510627 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 0.81675959 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81154413 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79943578 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78168729 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76119581 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.76025928 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.71838789 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70592920 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.70049951 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 0.69736098 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68393947 |
| 65 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67776681 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67190088 |
| 67 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.66911188 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66723814 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64765022 |
| 70 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64154778 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63273279 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61313208 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60425271 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.59010622 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.57847156 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56400509 |
| 77 | Homologous recombination_Homo sapiens_hsa03440 | 0.53458582 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.51973757 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51654895 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.50241378 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48287790 |
| 82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47745299 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47611071 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45463446 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45384455 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.43199602 |
| 87 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42008204 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41520451 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41456847 |
| 90 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41092965 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38428862 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37263955 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.36904323 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36902174 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36810791 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35457108 |
| 97 | DNA replication_Homo sapiens_hsa03030 | 0.32872066 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.32418561 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31720666 |
| 100 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.31415640 |

